Cladribine interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.
Nausea, Fatigue, Headache, Rash, Fever, Injection site allergic reaction
Cladribine is used in the treatment of ovarian cancer, head and neck cancer, cervical cancer, Testicular cancer., breast cancer, non-Hodgkin lymphoma (NHL), blood cancer, lung cancer, bone cancer and urinary bladder cancer.
Cladribine is not a vesicant (a chemical compound that causes severe skin, eye and mucosal pain and irritation)
Q. Is Cladribine FDA approved?Yes, Cladribine was approved by US FDA in 2004 to treat hairy cell leukemia (type of white blood cell cancer)
Q. Does Cladribine cause hair loss?No, Cladribine does not cause hair loss.